Berberine Attenuates Intestinal Mucosal Barrier Dysfunction in Type 2 Diabetic Rats.
about
Berberine Ameliorates Diabetes-Associated Cognitive Decline through Modulation of Aberrant Inflammation Response and Insulin Signaling Pathway in DM Rats.New Insights into the Mechanisms of Chinese Herbal Products on Diabetes: A Focus on the "Bacteria-Mucosal Immunity-Inflammation-Diabetes" Axis.Epithelial Barrier Function in Gut-Bone Signaling.Effect of Jiaotai Pill () on intestinal damage in partially sleep deprived rats.Comparative Proteomic Analysis of Two Differently Extracted Coptis chinensis in the Treatment of Type 2 Diabetic RatsBerberine Attenuated Proliferation, Invasion and Migration by Targeting the AMPK/HNF4α/WNT5A Pathway in Gastric Carcinoma
P2860
Berberine Attenuates Intestinal Mucosal Barrier Dysfunction in Type 2 Diabetic Rats.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Berberine Attenuates Intestinal Mucosal Barrier Dysfunction in Type 2 Diabetic Rats.
@en
Berberine Attenuates Intestinal Mucosal Barrier Dysfunction in Type 2 Diabetic Rats.
@nl
type
label
Berberine Attenuates Intestinal Mucosal Barrier Dysfunction in Type 2 Diabetic Rats.
@en
Berberine Attenuates Intestinal Mucosal Barrier Dysfunction in Type 2 Diabetic Rats.
@nl
prefLabel
Berberine Attenuates Intestinal Mucosal Barrier Dysfunction in Type 2 Diabetic Rats.
@en
Berberine Attenuates Intestinal Mucosal Barrier Dysfunction in Type 2 Diabetic Rats.
@nl
P2093
P2860
P356
P1476
Berberine Attenuates Intestinal Mucosal Barrier Dysfunction in Type 2 Diabetic Rats.
@en
P2093
Desen Yang
Dingkun Wang
Jingbin Li
Kaifu Wang
P2860
P356
10.3389/FPHAR.2017.00042
P577
2017-02-03T00:00:00Z